Sankala Group’s Astera Labs ALAB Stock Holding History

Sankala Group’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.7K	Hold	30	–	–	0.01%	369
2026 Q2	$8.97K	Hold	30	–	–	0.01%	410
2026 Q1	$3.4K	Hold	30	–	–	﹤0.01%	460
2025 Q4	$3.56K	Buy	+30	New	+$5.02K	﹤0.01%	471

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $200B AUM 30.19% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Sankala Group's ALAB Position: Q3 2026 in Review

Sankala Group held its Astera Labs (ALAB) position steady in Q3 2026 at 30 shares worth $10.7K. The position accounts for 0.01% of the portfolio, ranked #369.

Sankala Group first reported a position in ALAB in Q4 2025 and has held it in 4 quarters since. 568 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

Sankala Group held 30 shares of Astera Labs worth $10.7K as of Q3 2026.
Sankala Group left its Astera Labs share count unchanged in Q3 2026.
Astera Labs made up 0.01% of Sankala Group's portfolio in Q3 2026, its #369 holding.
Sankala Group first reported a position in Astera Labs in Q4 2025 and has held it in 4 quarters since.
568 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Sankala Group's 13F filing for Q3 2026, filed 9 Nov 2026.